Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 15, 2009
Boston Scientific today announced special items that will reduce its GAAP earnings for the first quarter
-
Apr 6, 2009
Company will webcast its April 21 call. Learn how to tune in.
-
Mar 31, 2009
Upheld District Court's decision that JNJ's Bx Velocity and Cypher Stent Systems infringe Boston Scientific's patent
-
Mar 31, 2009
Legislation will help evaluate the current state of chronic pain care in the United States
-
Mar 29, 2009Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms
Three-year results and two-year pooled analysis presented at ACC demonstrate continued positive outcomes for both PROMUS® and TAXUS® Stents
-
Mar 28, 2009
Analysis of economic and quality of life outcomes are based on one-year data from landmark SYNTAX trial
-
Mar 26, 2009
Presentations to include additional analyses of one-year data from the landmark SYNTAX study
-
Mar 25, 2009
Upgrade follows the Moody's actions of March 12, when it raised Company's outlook to stable from negative
-
Mar 19, 2009
iCross™ designed to improve the deliverability of Company's market-leading intravascular ultrasound (IVUS) technology
-
Mar 12, 2009
Rating agency notes that Company has been able to retain market share in the DES arena while rebuilding its CRM presence with new product launches